Biotechnology Assets, S.A. (BME:BST)

Biotechnology Assets Revenue

Biotechnology Assets had revenue of 1.11M EUR in the half year ending June 30, 2024, a decrease of -4.56%. This brings the company's revenue in the last twelve months to 3.37M, down -1.96% year-over-year. In the year 2023, Biotechnology Assets had annual revenue of 3.91M with 32.14% growth.

• Revenue (ttm): 3.37M
• Revenue Growth: -1.96%
• P/S Ratio: 6.11
• Revenue / Employee: 88.76K
• Employees: 37
• Market Cap: 21.33M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.91M	950.58K	32.14%
Dec 31, 2022	2.96M	-324.07K	-9.87%
Dec 31, 2021	3.28M	390.31K	13.50%
Dec 31, 2020	2.89M	-345.59K	-10.68%
Dec 31, 2019	3.24M	-21.99M	-87.17%